(Q36687379)

English

Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease

scientific article published on December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Spears

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

C McSharry

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

N C Thomson

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

1 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1494-1504

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Inhaled glucocorticoids for asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Update on glucocorticoid action and resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Significant variability in response to inhaled corticosteroids for persistent asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Severe asthma in adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

COPD: current therapeutic interventions and future approaches

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Emerging roles of PPARs in inflammation and immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Retinoids potentiate peroxisome proliferator-activated receptor gamma action in differentiation, gene expression, and lipid metabolic processes in developing myeloid cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive ox

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Inhibition of Interleukin-4 Production in CD4+T Cells by Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Ligands: Involvement of Physical Association between PPAR-γ and the Nuclear Factor of Activated T Cells Transcription Factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Nrf2, a multi-organ protector?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor-γ agonists in atherosclerosis: current evidence and future directions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

PPAR‐α and ‐γ but not ‐δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF‐κB‐independent effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

PPAR-gamma agonists as therapy for diseases involving airway neutrophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Redox regulation of PI 3-kinase signalling via inactivation of PTEN

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Interleukin (IL)-4 indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor gamma activated by macrophage-derived 12/15-lipoxygenase ligands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Repression of IFN-gamma expression by peroxisome proliferator-activated receptor gamma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Activation-induced PPARγ expression sensitizes primary human T cells toward apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor ligands negatively regulate the expression of the high-affinity IgE receptor Fc epsilon RI in human basophilic KU812 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Asthma. From bronchoconstriction to airways inflammation and remodeling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Phosphodiesterase inhibitors in airways disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor γ Associated With Carotid Atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02604.X

21 January 2018

Identifiers

10.1111/J.1365-2222.2006.02604.X

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36687379&oldid=1646416829"